-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Initiates Coverage On Upstream Bio with Outperform Rating, Announces Price Target of $51

Benzinga·12/18/2025 09:36:47
Listen to the news
Mizuho analyst Joseph Catanzaro initiates coverage on Upstream Bio (NASDAQ:UPB) with a Outperform rating and announces Price Target of $51.